Correlation Between ChitogenX and Marizyme
Can any of the company-specific risk be diversified away by investing in both ChitogenX and Marizyme at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ChitogenX and Marizyme into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ChitogenX and Marizyme, you can compare the effects of market volatilities on ChitogenX and Marizyme and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ChitogenX with a short position of Marizyme. Check out your portfolio center. Please also check ongoing floating volatility patterns of ChitogenX and Marizyme.
Diversification Opportunities for ChitogenX and Marizyme
Excellent diversification
The 3 months correlation between ChitogenX and Marizyme is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding ChitogenX and Marizyme in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marizyme and ChitogenX is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ChitogenX are associated (or correlated) with Marizyme. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marizyme has no effect on the direction of ChitogenX i.e., ChitogenX and Marizyme go up and down completely randomly.
Pair Corralation between ChitogenX and Marizyme
If you would invest 0.79 in ChitogenX on December 1, 2024 and sell it today you would lose (0.08) from holding ChitogenX or give up 10.13% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
ChitogenX vs. Marizyme
Performance |
Timeline |
ChitogenX |
Marizyme |
ChitogenX and Marizyme Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ChitogenX and Marizyme
The main advantage of trading using opposite ChitogenX and Marizyme positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ChitogenX position performs unexpectedly, Marizyme can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marizyme will offset losses from the drop in Marizyme's long position.ChitogenX vs. Tiziana Life Sciences | ChitogenX vs. Acurx Pharmaceuticals LLC | ChitogenX vs. Aadi Bioscience | ChitogenX vs. Aquagold International |
Marizyme vs. NRx Pharmaceuticals | Marizyme vs. RenovaCare | Marizyme vs. Aerovate Therapeutics | Marizyme vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |